i want to
Office Practice Information:
Thomas G. Gross, MD, PhD is a member of the Division of Hematology/Oncology/BMT at Nationwide Children’s Hospital, a member of the Center of Childhood Cancer Research at Nationwide Children’s Research Institute and a Professor of Pediatrics at The Ohio State University College of Medicine. He serves on the Institutional Review Board and Clinical Research Scientific Council and is a member of the Pediatric Oncology and Viral Oncogenesis Program at the NCIdesignated Comprehensive Cancer Center at The Ohio State University. His clinical interests are BMT and the treatment of cancers in immunocompromised patients, such as post-transplant lymphoproliferative disease (PTLD). His research interests are focused on transplant and tumor immunology. He is the Principal Investigator for the PTLD clinical trial in the Children’s Oncology Group (COG), and is the Chair of the Non-Hodgkin’s Lymphoma (NHL) Disease Committee in COG. Dr. Gross is co-investigator on several NIH-funded clinical studies in transplantation and NHL. He serves on the Pediatric Cancer Editorial Board for the Physician Data Query at the National Cancer Institute, on the Board of Trustees of the National Childhood Cancer Foundation and the Board of Directors of the Israel Penn International Transplant Tumor Registry. He is a member of several committees for the Pediatric Blood and Marrow Transplant Consortium, Center for International Blood and Marrow Transplant Research, International Pediatric Transplantation Association, American Society of Transplantation, as well as scientific advisory committees for several pharmaceutical companies.
Associate Professor, Department of Pediatrics, The Ohio State University Medical School, Columbus, OH